Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on the FDA’s ‘Fit-for-Purpose Rare…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the FDA’s ‘Fit-for-Purpose Rare Disease Framework Initiative.’“Today’s announcement is an important step…
Learn more
BIO Statement on Finalization of the Globe Model
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the finalization of the GLOBE model.“Biotechnology is one of America's greatest strengths, delivering…
Learn more
Nevada Governor Joe Lombardo Named BIO’s Governor…
WASHINGTON, DC (August 31, 2026) – Today, the Biotechnology Innovation Organization (BIO) awarded Nevada Governor Joe Lombardo with its 2026 Governor of the Year Award, recognizing his leadership in growing the life sciences in Nevada and commitment…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
New CMS Reimbursement Rule “Reaffirms the Many Benefits of Transformational Therapies”
September 2, 2020
Today, the Centers for Medicare and Medicaid Services finalized this year’s inpatient prospective payment system (IPPS) rule, which includes a new diagnosis-related group (DRG) to streamline reimbursements for providers administering CAR T-cell…
EPA Rulemaking Recognizes the Importance of Innovation
September 1, 2020
Washington, D.C. (September 1, 2020) – A U.S. regulatory system that keeps pace with science will put much-needed tools into the hands of farmers, help combat climate change, and advance sustainable farming practices, according to the Biotechnology…
Inova and BIO Launch New Virtual Partnering Series
August 31, 2020
  Today, Inova Software and the Biotechnology Innovation Organization (BIO) are announcing the first international series of virtual partnering events focused on three critical therapeutic areas with great unmet need -  oncology,…
BIO: FDA Oversight of Animal Biotechnology Must Be Changed
August 19, 2020
America’s position as an innovation leader is at stake  Washington, D.C. (August 19, 2020) – The U.S. government’s system for regulating animal biotechnology – currently under the U.S. Food and Drug Administration (FDA) – is broken and is…
Ensuring Scientific Justice by Building Bridges to Minority Communities is Centerpiece of BIOEquality Agenda
August 6, 2020
New focus on justice through equity in diverse clinical trials, STEM education and expanding entrepreneurship to undeserved communities will drive nation’s largest life science advocacy organization The Biotechnology Innovation Organization (BIO)…
American Producers’ Access to Biotech Innovation Critical to Strengthening Economy and Addressing Climate Change
July 31, 2020
Today, the Biotechnology Innovation Organization (BIO) submitted its comments in response to the U.S. Department of Agriculture’s (UDSA) Solicitation of Input from Stakeholders on Agricultural Innovations, part of the Department’s Agriculture…
BIO Announces New Leadership for Food and Agriculture Section Governing Board
July 29, 2020
Washington, D.C. (July 29, 2020) – The Food and Agriculture Section of the Biotechnology Innovation Organization (BIO) is pleased to announce the election of its new Board leadership. Sylvia Wulf, CEO of AquaBounty Technologies, Inc., and Brian…
BIO’s Dr. McMurry-Heath Warns Executive Order to “Cripple Small, Innovative Companies” Working to Eradicate COVID-19
July 24, 2020
Says biopharma researchers and scientists stand ready to support real solutions that will address patient drug costs, continue lifesaving science Dr. Michelle McMurry-Heath, the president and CEO of the Biotechnology Innovation Organization (BIO),…
BIO CEO Defends Dr. Fauci, Says Criticisms “Undermine Our Response to this Pandemic”
July 16, 2020
In response to attacks on Dr. Anthony Fauci’s credibility and character, BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement: “As this global pandemic continues to wreak havoc, we must stand behind the scientists and…
Biopharmaceutical Leaders Announce New Effort to Tackle Superbugs, Spur Development of New Antibiotics
July 9, 2020
Today more than 20 leading biopharmaceutical companies announced the creation of an estimated $1 billion fund to help support the pipeline for new antibiotic treatments. The AMR Action Fund was launched as the threat of antimicrobial resistance, or…